Earp Brian D, Sandberg Anders, Savulescu Julian
Camb Q Healthc Ethics. 2015 Jul;24(3):323-36. doi: 10.1017/S0963180114000206. Epub 2014 Jun 17.
Pharmaceuticals or other emerging technologies could be used to enhance (or diminish) feelings of lust, attraction, and attachment in adult romantic partnerships. Although such interventions could conceivably be used to promote individual (and couple) well-being, their widespread development and/or adoption might lead to the 'medicalization' of human love and heartache--for some, a source of a serious concern. In this essay, we argue that the medicalization of love need not necessarily be problematic, on balance, but could plausibly be expected to have either good or bad consequences depending upon how it unfolds. By anticipating some of the specific ways in which these technologies could yield unwanted outcomes, bioethicists and others can help to direct the course of love's medicalization--should it happen to occur--more toward the 'good' side than the 'bad.'
药物或其他新兴技术可用于增强(或减弱)成年浪漫伴侣关系中的欲望、吸引力和依恋感。尽管可以想象这些干预措施可用于促进个人(及伴侣)的幸福,但它们的广泛发展和/或采用可能会导致人类爱情和心痛的“医学化”——对一些人来说,这是一个严重担忧的根源。在本文中,我们认为,总体而言,爱情的医学化不一定会有问题,但根据其发展情况,可能会产生好的或坏的后果。通过预测这些技术可能产生不良后果的一些具体方式,生物伦理学家和其他人可以帮助引导爱情医学化的进程(如果它真的发生的话),使其更多地走向“好”的一面而非“坏”的一面。